Jiangxi Serum Pharma Industries Co., Ltd. stands as a titan in the professional supply of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, and intermediates, establishing a benchmark for E-E-A-T principles in the plasma derivative industry.
With a robust network and deep industry experience, we specialize in Human Prothrombin Complex (PCC) procurement, ensuring that life-saving hemostatic agents reach hospitals, clinics, and emergency centers worldwide with uncompromising purity and speed.
Our PCC supply chain is governed by rigorous GMP, BP, and USP standards. We don't just supply products; we provide clinical reliability through multi-stage pathogen inactivation and specialized protein fractionation technologies.
The global market for Human Prothrombin Complex Concentrate (PCC) is witnessing a transformative era driven by the aging global population and the increasing prevalence of cardiovascular diseases requiring oral anticoagulants. As a leading Wholesale Human Prothrombin Complex Supplier, we observe the following pivotal trends:
By integrating plasma collection (apheresis) with high-throughput fractionation centers, Chinese manufacturers reduce lead times by 30% compared to traditional European hubs.
Utilizing AI-driven cold chain monitoring, we ensure that every vial of Human Prothrombin Complex maintains a strict 2°C to 8°C profile from the factory floor to the destination port.
Our "Factory 4.0" model leverages automated chromatography and ultrafiltration systems, allowing for high-purity protein extraction at a cost-efficiency that benefits global wholesale buyers.
Serum Pharma continuously monitors cutting-edge market developments. We have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization, and Bio-Fermentation product services. Our pharmaceutical portfolio consists of biological products, vaccines, western medicines, and raw materials—all crafted to bring back health through purity and balance.
Optimized formulations for rapid clinical deployment.
Enhancing stability and bioavailability of medical intermediates.
Advanced microbial technology for high-purity extracts.
In acute ER settings, PCC is the first-line treatment for life-threatening bleeds, offering faster onset than Fresh Frozen Plasma (FFP).
Used in cardiac and orthopedic surgeries to manage intraoperative bleeding in patients with pre-existing coagulation factor deficiencies.
Supplying specialized PCC for the treatment of coagulopathy secondary to severe liver disease or chronic cirrhosis.
Typically, our PCC has a shelf life of 24 to 36 months when stored under validated cold chain conditions (2-8°C).
Yes, we provide full DMF (Drug Master File), GMP certificates, and stability data to assist our wholesale partners in local registration.
The MOQ varies based on regional demand and stock levels; please contact our export department for a customized quote.
We utilize a multi-pronged approach including donor screening, plasma testing (NAT), solvent-detergent treatment, and nanofiltration (20nm).
